Skip to Main content Skip to Navigation
New interface
Journal articles

An innovative strategy for the molecular diagnosis of Usher syndrome identifies causal biallelic mutations in 93% of European patients

Crystel Bonnet 1 Zied Riahi 1 Sandra Chantot-Bastaraud 2 Luce Smagghe 1 Mélanie Letexier 3 Charles Marcaillou 3 Gaëlle Lefèvre 1 Jean-Pierre Hardelin 4 Aziz El-Amraoui 4 Amrit Singh-Estivalet 1 Saddek Mohand-Saïd 5, 1 Susanne Kohl 6 Anne Kurtenbach 6 Ieva Sliesoraityte 5, 6 Ditta Zobor 6 Souad Gherbi 7 Francesco Testa 8 Francesca Simonelli 8 Sandro Banfi 9, 10 Ana Fakin 11 Damjan Glavač 12 Martina Jarc-Vidmar 11 Andrej Zupan 12 Saba Battelino 11 Loreto Martorell Sampol 13 Maria Antonia Claveria 13 Jaume Catala Mora 13 Shzeena Dad 14 Lisbeth Møller 14 Jesus Rodriguez Jorge 13 Marko Hawlina 11 Alberto Auricchio 9, 8 José-Alain Sahel 1, 5 Sandrine Marlin 7 Eberhart Zrenner 15 Isabelle Audo 1, 5 Christine Petit 1, 4, 16, * 
Abstract : Usher syndrome (USH), the most prevalent cause of hereditary deafness-blindness, is an autosomal recessive and genetically heterogeneous disorder. Three clinical subtypes (USH1-3) are distinguishable based on the severity of the sensorineural hearing impairment, the presence or absence of vestibular dysfunction, and the age of onset of the retinitis pigmentosa. A total of 10 causal genes, 6 for USH1, 3 for USH2, and 1 for USH3, and an USH2 modifier gene, have been identified. A robust molecular diagnosis is required not only to improve genetic counseling, but also to advance gene therapy in USH patients. Here, we present an improved diagnostic strategy that is both cost- and time-effective. It relies on the sequential use of three different techniques to analyze selected genomic regions: targeted exome sequencing, comparative genome hybridization, and quantitative exon amplification. We screened a large cohort of 427 patients (139 USH1, 282 USH2, and six of undefined clinical subtype) from various European medical centers for mutations in all USH genes and the modifier gene. We identified a total of 421 different sequence variants predicted to be pathogenic, about half of which had not been previously reported. Remarkably, we detected large genomic rearrangements, most of which were novel and unique, in 9% of the patients. Thus, our strategy led to the identification of biallelic and monoallelic mutations in 92.7% and 5.8% of the USH patients, respectively. With an overall 98.5% mutation characterization rate, the diagnosis efficiency was substantially improved compared with previously reported methods.
Document type :
Journal articles
Complete list of metadata

https://hal-pasteur.archives-ouvertes.fr/pasteur-03215026
Contributor : Crystel Bonnet Connect in order to contact the contributor
Submitted on : Monday, May 3, 2021 - 10:13:13 AM
Last modification on : Wednesday, December 7, 2022 - 2:26:08 PM
Long-term archiving on: : Wednesday, August 4, 2021 - 6:19:14 PM

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Citation

Crystel Bonnet, Zied Riahi, Sandra Chantot-Bastaraud, Luce Smagghe, Mélanie Letexier, et al.. An innovative strategy for the molecular diagnosis of Usher syndrome identifies causal biallelic mutations in 93% of European patients. European Journal of Human Genetics, 2016, 24 (12), pp.1730-1738. ⟨10.1038/ejhg.2016.99⟩. ⟨pasteur-03215026⟩

Share

Metrics

Record views

53

Files downloads

28